SCHEMBL14083340

SCHEMBL14083340

COCCNc1cc(-c2ncccc2Cl)ccc1C(=O)Nc1ccnc(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.42
▸ TRPV1 Q8NER1 4/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ JAK1 P23458 1/20 0.41
▸ TYK2 P29597 1/20 0.41
▸ NTRK1 P04629 2/20 0.41
▸ GRM4 Q14833 2/20 0.39
▸ KIT P10721 1/20 0.39
▸ BRAF P15056 1/20 0.39
▸ GRM5 P41594 1/20 0.38
▸ SMARCA2 P51531 2/20 0.38
▸ SMARCA4 P51532 2/20 0.38
▸ CDC7 O00311 1/20 0.37
▸ ROCK2 O75116 1/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ PRKACA P17612 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083321 0.90 RXFP1 (0.46) RXFP1TRPV1KDM4EALDH1A1SMN1; SMN2
SCHEMBL14083325 0.89 TRPV1 (0.48) RXFP1TRPV1KDM4EALDH1A1SMN1; SMN2
SCHEMBL14083338 0.88 TRPV1 (0.43) RXFP1HSP90AA1TRPV1KDM4EALDH1A1
SCHEMBL14083322 0.87 GRM4 (0.49) RXFP1HSP90AA1KDM4EALDH1A1SMN1; SMN2
SCHEMBL14083326 0.87 GRM4 (0.53) TRPV1KDM4EALDH1A1SMN1; SMN2GRM4
SCHEMBL14083330 0.86 TRPV1 (0.48) RXFP1TRPV1ALDH1A1SMN1; SMN2NTRK1
SCHEMBL14083331 0.85 TRPV1 (0.62) TRPV1
SCHEMBL14083329 0.85 TRPV1 (0.51) RXFP1TRPV1SMN1; SMN2GRM4BRAF
SCHEMBL14083341 0.85 RXFP1 (0.64) RXFP1TRPV1ALDH1A1KIT
SCHEMBL14083327 0.85 TRPV1 (0.61) RXFP1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 RXFP1 1053/4885HSP90AA1 734/4885TRPV1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback